Page last updated: 2024-08-25

rosiglitazone and Lymphoma, Large B-Cell, Diffuse

rosiglitazone has been researched along with Lymphoma, Large B-Cell, Diffuse in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	1 (100.00)	2.80

Authors

Authors	Studies
Li, Q; Rao, J; Yang, C; Yang, H; Zhang, W; Zhang, X	1

Other Studies

1 other study(ies) available for rosiglitazone and Lymphoma, Large B-Cell, Diffuse

Article	Year
Curcumin exerts anti-tumor effects on diffuse large B cell lymphoma via regulating PPARγ expression. Biochemical and biophysical research communications, 2020, 03-26, Volume: 524, Issue:1 Topics: Anilides; Animals; Antineoplastic Agents; Apoptosis; Cell Cycle Checkpoints; Cell Line, Tumor; Cell Proliferation; Curcumin; Gene Expression Regulation, Neoplastic; Humans; Lymphoma, Large B-Cell, Diffuse; Mice, SCID; Neoplasms, Experimental; PPAR gamma; Proto-Oncogene Proteins c-akt; Rosiglitazone; Signal Transduction; TOR Serine-Threonine Kinases	2020

Article

Year

Curcumin exerts anti-tumor effects on diffuse large B cell lymphoma via regulating PPARγ expression.

Biochemical and biophysical research communications, 2020, 03-26, Volume: 524, Issue:1

Topics: Anilides; Animals; Antineoplastic Agents; Apoptosis; Cell Cycle Checkpoints; Cell Line, Tumor; Cell Proliferation; Curcumin; Gene Expression Regulation, Neoplastic; Humans; Lymphoma, Large B-Cell, Diffuse; Mice, SCID; Neoplasms, Experimental; PPAR gamma; Proto-Oncogene Proteins c-akt; Rosiglitazone; Signal Transduction; TOR Serine-Threonine Kinases

2020